133 related articles for article (PubMed ID: 11327536)
1. Peripheral progenitor cells (PBPC) in supportive care after high-dose chemotherapy in breast cancer.
Filip S; Bláha M; Petera J; Vavrová J; Knízek J
Neoplasma; 2001; 48(1):39-47. PubMed ID: 11327536
[TBL] [Abstract][Full Text] [Related]
2. The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients.
Filip S; Vanásek J; Bláha M; Mericka P; Vávrová J; Podzimek K
Neoplasma; 1999; 46(3):166-72. PubMed ID: 10613592
[TBL] [Abstract][Full Text] [Related]
3. Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer.
Vanásek J; Filip S; Medková V; Bláha M; Maricka P; Stránský P; Vavrová J
Neoplasma; 2001; 48(1):34-8. PubMed ID: 11327535
[TBL] [Abstract][Full Text] [Related]
4. The emergence of peripheral blood progenitor cells to support intensive chemotherapy for patients with breast cancer.
Demetri GD
Pharmacotherapy; 1996; 16(3 Pt 2):94S-100S. PubMed ID: 8726588
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
6. [Autologous hematopoietic stem cell transplantation--application to recurrent breast cancer].
Mukaiyama T; Ogawa M
Gan To Kagaku Ryoho; 1990 Oct; 17(10):1989-96. PubMed ID: 1699496
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood progenitor cell transplantation for breast cancer: pharmacoeconomic considerations.
Gilbert CJ
Pharmacotherapy; 1996; 16(3 Pt 2):101S-108S. PubMed ID: 8726589
[TBL] [Abstract][Full Text] [Related]
8. High-dose carboplatin, cyclophosphamide, etoposide with hematological growth factors, without stem cell support in patients with advanced cancer.
Recchia F; De Fillipis S; Piccinini M; Rea S
Anticancer Res; 2003; 23(5b):4141-7. PubMed ID: 14666615
[TBL] [Abstract][Full Text] [Related]
9. The utilization of cytokines in stem cell mobilization strategies.
Shpall EJ
Bone Marrow Transplant; 1999 May; 23 Suppl 2():S13-9. PubMed ID: 10335872
[TBL] [Abstract][Full Text] [Related]
10. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
11. Mobilization of peripheral blood progenitor cells with paclitaxel-based chemotherapy.
Shea TC
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-105-S2-107. PubMed ID: 9045326
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-mobilized peripheral blood progenitor cells.
Nemunaitis J
Semin Oncol; 1996 Apr; 23(2 Suppl 4):9-14. PubMed ID: 8600547
[TBL] [Abstract][Full Text] [Related]
13. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
[TBL] [Abstract][Full Text] [Related]
14. Dose intensity in small cell lung cancer.
Thatcher N; Lee SM; Woll PJ; Middleton M; Anderson H; Burt P; Stout R
Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057
[TBL] [Abstract][Full Text] [Related]
15. Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers.
Weaver CH; Schwartzberg LS; Hainsworth J; Greco FA; Li W; Buckner CD; West WH
Bone Marrow Transplant; 1997 Apr; 19(7):671-8. PubMed ID: 9156243
[TBL] [Abstract][Full Text] [Related]
16. High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Tarella C; Di Nicola M; Caracciolo D; Zallio F; Cuttica A; Omedè P; Bondesan P; Magni M; Matteucci P; Gallamini A; Pileri A; Gianni AM
Bone Marrow Transplant; 2002 Dec; 30(11):725-32. PubMed ID: 12439694
[TBL] [Abstract][Full Text] [Related]
17. Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
Torretta L; Perotti C; Pedrazzoli P; Dornini G; Viarengo G; Livraghi A; Noris P; Da Prada GA; Balduini CL; della Cuna GR; Salvaneschi L
Vox Sang; 1998; 75(3):224-9. PubMed ID: 9852411
[TBL] [Abstract][Full Text] [Related]
18. Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high-dose cyclophosphamide: a retrospective review of 141 patients.
Assouline S; Sylvestre MP; Carriere P; Shustik C; Laneuville P
Transfusion; 2006 Feb; 46(2):174-9. PubMed ID: 16441591
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients.
Zambelli A; Montagna D; Da Prada GA; Maccario R; Zibera C; Moretta A; Ponchio L; Lozza L; Baiardi P; Maserati R; Marone P; Della Cuna GR
Anticancer Res; 2002; 22(6B):3701-8. PubMed ID: 12552979
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
